Novartis

News

Novartis CAR-T safety in FDA spotlight

FDA advisers are set to make recommendations on Novartis’ groundbreaking CAR-T therapy CTL019 tomorrow – and are set to focus on safety concerns in the decisive meeting.

News

Oxford BioMedica are working with Novartis to produce the 'living drug' CAR-T therapy Illustration: Novartis

Oxford BioMedica signs $100m CAR-T deal with Novartis

UK firm to supply viruses to generate CAR-T therapies

News

Novartis' psoriasis drug gets label boost

New label shows Cosentyx is superior to J&J's rival in long-term.

News

A sad young woman is sitting in her kitchen with a headache

Alder shares slump despite migraine success

Investors concerned over strong placebo effect

News

NICE recommends Sanofi's Gaucher treatment

Cancer drugs from Novartis and Pfizer also backed

News

Kisqali set for approval - but likely to hit same NICE obsta...

Concerns that NICE will reject Kisqali like it did Ibrance.

Novartis CAR-T safety in FDA spotlight

Oxford BioMedica signs $100m CAR-T deal with Novartis

Novartis' psoriasis drug gets label boost

Alder shares slump despite migraine success

NICE recommends Sanofi's Gaucher treatment

Kisqali set for approval - but likely to hit same NICE obsta...

GBL joins CVC in €10.7bn takeover bid for Recordati

Discover a new era of healthcare panel engagement: Grounded ...

Novartis

Editor's Picks